K. Penner

410 total citations
9 papers, 290 citations indexed

About

K. Penner is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, K. Penner has authored 9 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Obstetrics and Gynecology, 5 papers in Reproductive Medicine and 4 papers in Surgery. Recurrent topics in K. Penner's work include Endometrial and Cervical Cancer Treatments (6 papers), Ovarian cancer diagnosis and treatment (4 papers) and Estrogen and related hormone effects (2 papers). K. Penner is often cited by papers focused on Endometrial and Cervical Cancer Treatments (6 papers), Ovarian cancer diagnosis and treatment (4 papers) and Estrogen and related hormone effects (2 papers). K. Penner collaborates with scholars based in United States and Brazil. K. Penner's co-authors include Krista S. Pfaendler, Lari Wenzel, Mindy B. Mechanic, Nicole D. Fleming, Allison E. Axtell, Scott E. Lentz, Robert E. Bristow, Jenny Chang, Argyrios Ziogas and Nora Ostrzega and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Obstetrics and Gynecology and Obstetrics and Gynecology.

In The Last Decade

K. Penner

9 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Penner United States 6 137 115 71 62 56 9 290
Mette Moustgaard Jeppesen Denmark 9 162 1.2× 145 1.3× 98 1.4× 39 0.6× 65 1.2× 18 327
Linda Hertlein Germany 10 113 0.8× 67 0.6× 173 2.4× 31 0.5× 77 1.4× 18 378
Julia Fehniger United States 11 43 0.3× 134 1.2× 71 1.0× 43 0.7× 36 0.6× 25 397
Frederico Soares Falcetta Brazil 7 79 0.6× 88 0.8× 76 1.1× 84 1.4× 85 1.5× 21 320
Ana M. Angarita United States 8 54 0.4× 53 0.5× 56 0.8× 29 0.5× 43 0.8× 22 202
Philippa Pearmain United Kingdom 8 105 0.8× 123 1.1× 65 0.9× 131 2.1× 30 0.5× 16 327
Setareh Akhavan Iran 10 82 0.6× 46 0.4× 59 0.8× 56 0.9× 58 1.0× 57 291
Jason A. Lachance United States 13 223 1.6× 104 0.9× 178 2.5× 128 2.1× 117 2.1× 18 442
Dorry Boll Netherlands 12 42 0.3× 134 1.2× 27 0.4× 61 1.0× 41 0.7× 25 285
Michael Richardson United States 10 53 0.4× 77 0.7× 91 1.3× 19 0.3× 38 0.7× 37 296

Countries citing papers authored by K. Penner

Since Specialization
Citations

This map shows the geographic impact of K. Penner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Penner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Penner more than expected).

Fields of papers citing papers by K. Penner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Penner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Penner. The network helps show where K. Penner may publish in the future.

Co-authorship network of co-authors of K. Penner

This figure shows the co-authorship network connecting the top 25 collaborators of K. Penner. A scholar is included among the top collaborators of K. Penner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Penner. K. Penner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Tewari, Krishnansu S., Robert E. Bristow, Fabio Cappuccini, et al.. (2021). Platinum resistance in gynecologic malignancies: Response, disease free and overall survival are predicted by biochemical signature: A metabolomic analysis. Gynecologic Oncology. 163(1). 162–170. 9 indexed citations
2.
Liang, Margaret, Emily Prendergast, Avisek Datta, et al.. (2019). Clinical outcomes in ovarian cancer patients receiving three versus more cycles of chemotherapy after neoadjuvant treatment and interval cytoreductive surgery. International Journal of Gynecological Cancer. 29(7). 1156–1163. 6 indexed citations
3.
Pfaendler, Krista S., Jenny Chang, Argyrios Ziogas, Robert E. Bristow, & K. Penner. (2018). Disparities in Adherence to National Comprehensive Cancer Network Treatment Guidelines and Survival for Stage IB–IIA Cervical Cancer in California. Obstetrics and Gynecology. 131(5). 899–908. 43 indexed citations
4.
Pfaendler, Krista S., Lari Wenzel, Mindy B. Mechanic, & K. Penner. (2015). Cervical Cancer Survivorship: Long-term Quality of Life and Social Support. Clinical Therapeutics. 37(1). 39–48. 128 indexed citations
6.
Penner, K., et al.. (2014). Same-day discharge is feasible and safe in patients undergoing minimally invasive staging for gynecologic malignancies. American Journal of Obstetrics and Gynecology. 212(2). 186.e1–186.e8. 60 indexed citations
7.
Chang, Jenny, et al.. (2014). Disparities in Access to Minimally Invasive Surgery for Women Undergoing Hysterectomy in California. Obstetrics and Gynecology. 123(Supplement 1). 28S–28S. 1 indexed citations
8.
Penner, K., Oliver Dorigo, Chisa Aoyama, et al.. (2011). Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy. Gynecologic Oncology. 124(3). 542–548. 41 indexed citations
9.
Penner, K., Oliver Dorigo, Christine Walsh, Ilana Cass, & Christine H. Holschneider. (2008). Multi-institutional study identifying predictors of response to progestin treatment of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma. Gynecologic Oncology. 111(2). 379–379. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026